Media Thread, page-12968

Sounds lovely.

But $100 SP would give a MC of $800B.

The largest biotech in the world currently has a MC less than that.

Merck, Roche, Pfizer and Novartis all combined currently have a total MC around US$800B MC. And they have some blockbuster drugs both in oncology and other spaces (such as the lucrative cholesterol lowering drugs).

An $8-40B takeover ($1-5 SP) within the next 3-5 years? Maaayyyybe.

Or if Imugene fend off TOs and contine for the next 5-10 years then maybe be amoung some of those big biotechs if we have a good market share in multiple indications, some through licensing agreements, some kept in-house.

IMO of course.